Superoxide dismutase 3 prevents early stage diabetic retinopathy in streptozotocin-induced diabetic rat model.
Ji-Yeon LeeMirinae KimSu Bin OhHae-Young KimChongtae KimTae-Yoon KimYoung-Hoon ParkPublished in: PloS one (2022)
SOD3 treatment attenuated the loss of a/b-wave amplitudes in the diabetic rats, which was consistent with the immunohistochemical evaluation. We also suggest that in rod-dominant rodents, the use of blue on green photopic negative response (PhNR) is effective in measuring the inner retinal function in animal models of diabetic retinopathy. SOD3 treatment ameliorated the retinal Müller cell activation in diabetic rats and pericyte dysfunction. These results suggested that SOD3 exerted protective effects on the development of diabetic retinopathy.
Keyphrases
- diabetic retinopathy
- diabetic rats
- oxidative stress
- optical coherence tomography
- early stage
- amyotrophic lateral sclerosis
- type diabetes
- single cell
- squamous cell carcinoma
- combination therapy
- mesenchymal stem cells
- stem cells
- mouse model
- nitric oxide
- hydrogen peroxide
- lymph node
- insulin resistance
- bone marrow
- endothelial cells
- high glucose
- locally advanced